NeuroproteXeon Overview

  • Founded
  • 2014

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 3

NeuroproteXeon General Information


Provider of late clinical-stage pharmaceutical and medical devices based in New York. The company's inhalation device protects against brain cell death following acute neurologic injury.

Contact Information

Ownership Status
Financing Status
Corporate Backed or Acquired
Primary Industry
Therapeutic Devices
Other Industries
Drug Discovery
Invero Pharma
Primary Office
  • 50 Cobham Drive
  • Orchard Park
  • New York, NY 14127
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NeuroproteXeon Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore NeuroproteXeon‘s full profile, request access.

Request a free trial